19-50255315-G-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001145809.2(MYH14):​c.2041G>C​(p.Gly681Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00483 in 1,550,188 control chromosomes in the GnomAD database, including 316 homozygotes. In-silico tool predicts a benign outcome for this variant. 10/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.026 ( 173 hom., cov: 32)
Exomes 𝑓: 0.0026 ( 143 hom. )

Consequence

MYH14
NM_001145809.2 missense

Scores

1
2
10

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 2.06

Publications

2 publications found
Variant links:
Genes affected
MYH14 (HGNC:23212): (myosin heavy chain 14) This gene encodes a member of the myosin superfamily. The protein represents a conventional non-muscle myosin; it should not be confused with the unconventional myosin-14 (MYO14). Myosins are actin-dependent motor proteins with diverse functions including regulation of cytokinesis, cell motility, and cell polarity. Mutations in this gene result in one form of autosomal dominant hearing impairment. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2011]
MYH14 Gene-Disease associations (from GenCC):
  • autosomal dominant nonsyndromic hearing loss 4A
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • peripheral neuropathy-myopathy-hoarseness-hearing loss syndrome
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • nonsyndromic genetic hearing loss
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • autosomal dominant nonsyndromic hearing loss
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.002783388).
BP6
Variant 19-50255315-G-C is Benign according to our data. Variant chr19-50255315-G-C is described in ClinVar as Benign. ClinVar VariationId is 44054.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0861 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MYH14NM_001145809.2 linkc.2041G>C p.Gly681Arg missense_variant Exon 17 of 43 ENST00000642316.2 NP_001139281.1 Q7Z406-2A1L2Z2B3KWH4
MYH14NM_001077186.2 linkc.1946-1984G>C intron_variant Intron 16 of 41 NP_001070654.1 Q7Z406-6B3KWH4
MYH14NM_024729.4 linkc.1922-1984G>C intron_variant Intron 15 of 40 NP_079005.3 Q7Z406-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MYH14ENST00000642316.2 linkc.2041G>C p.Gly681Arg missense_variant Exon 17 of 43 NM_001145809.2 ENSP00000493594.1 Q7Z406-2

Frequencies

GnomAD3 genomes
AF:
0.0257
AC:
3902
AN:
152086
Hom.:
175
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0886
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0103
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000415
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000500
Gnomad OTH
AF:
0.0191
GnomAD2 exomes
AF:
0.00555
AC:
852
AN:
153548
AF XY:
0.00427
show subpopulations
Gnomad AFR exome
AF:
0.0902
Gnomad AMR exome
AF:
0.00389
Gnomad ASJ exome
AF:
0.000235
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000402
Gnomad OTH exome
AF:
0.00161
GnomAD4 exome
AF:
0.00256
AC:
3578
AN:
1397984
Hom.:
143
Cov.:
30
AF XY:
0.00223
AC XY:
1540
AN XY:
689612
show subpopulations
African (AFR)
AF:
0.0908
AC:
2864
AN:
31546
American (AMR)
AF:
0.00482
AC:
172
AN:
35696
Ashkenazi Jewish (ASJ)
AF:
0.000238
AC:
6
AN:
25174
East Asian (EAS)
AF:
0.0000280
AC:
1
AN:
35720
South Asian (SAS)
AF:
0.000353
AC:
28
AN:
79216
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
48576
Middle Eastern (MID)
AF:
0.00579
AC:
33
AN:
5696
European-Non Finnish (NFE)
AF:
0.000148
AC:
160
AN:
1078380
Other (OTH)
AF:
0.00542
AC:
314
AN:
57980
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
160
320
481
641
801
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
92
184
276
368
460
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0257
AC:
3905
AN:
152204
Hom.:
173
Cov.:
32
AF XY:
0.0243
AC XY:
1807
AN XY:
74430
show subpopulations
African (AFR)
AF:
0.0885
AC:
3671
AN:
41490
American (AMR)
AF:
0.0103
AC:
157
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.000288
AC:
1
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.000415
AC:
2
AN:
4816
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000500
AC:
34
AN:
68022
Other (OTH)
AF:
0.0189
AC:
40
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
173
346
518
691
864
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
42
84
126
168
210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00238
Hom.:
10
Bravo
AF:
0.0290
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.000259
AC:
1
ExAC
AF:
0.00831
AC:
219
Asia WGS
AF:
0.00520
AC:
18
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Aug 10, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Nov 06, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:2
May 07, 2012
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Gly681Arg in Exon 17 of MYH14: This variant is not expected to have clinical sig nificance because it has been identified in 9.5% (67/702) of African American ch romosomes from a broad population by the NHLBI Exome Sequencing Project (http:// evs.gs.washington.edu/EVS; dbSNP rs75915336). -

Feb 25, 2021
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.17
BayesDel_addAF
Benign
-0.46
T
BayesDel_noAF
Benign
-0.37
CADD
Uncertain
24
DANN
Benign
0.95
Eigen
Benign
-0.50
Eigen_PC
Benign
-0.40
FATHMM_MKL
Uncertain
0.83
D
LIST_S2
Benign
0.55
.;T
MetaRNN
Benign
0.0028
T;T
MetaSVM
Benign
-1.0
T
PhyloP100
2.1
PrimateAI
Pathogenic
0.79
T
Sift4G
Uncertain
0.0060
.;D
Polyphen
0.0030
B;B
Vest4
0.21
MutPred
0.36
Gain of solvent accessibility (P = 0.0097);Gain of solvent accessibility (P = 0.0097);
MVP
0.082
MPC
1.2
ClinPred
0.0034
T
GERP RS
3.2
gMVP
0.49
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs75915336; hg19: chr19-50758572; API